Long half-life and prolonged-release dopamine receptor agonists: a review of ropinirole prolonged-release studies-Reference-Cited by-同舟云学术

Long half-life and prolonged-release dopamine receptor agonists: a review of ropinirole prolonged-release studies

Published:2009-12 Issue: Volume:15 Page:S85-S92
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Onofrj M.,Bonanni L.,De Angelis M.V.,Anzellotti F.,Ciccocioppo F.,Thomas A.

Publisher

Elsevier BV

Subject

Neurology (clinical),Geriatrics and Gerontology,Neurology

Reference22 articles.

1. Continuous administration decreases and pulsatile administration increases behavioral sensitivity to a novel dopamine D2 agonist (U-91356A) in MPTP-exposed monkeys;Blanchet;J Pharmacol Exp Ther,1995

2. Treatments for Parkinson disease – past achievements and current clinical needs;Poewe;Neurology,2009

3. Cabergoline: a review of its efficacy in the treatment of Parkinson's disease;Wiseman;CNS Drugs,1999

4. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study;Bracco;CNS Drugs,2004

5. Efficacy of cabergoline in long-term use: results of three observational studies in 1,500 patients with Parkinson's disease;Baas;Eur Neurol,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amorphous Ropinirole-Loaded Mucoadhesive Buccal Film: A Potential Patient-Friendly Tool to Improve Drug Pharmacokinetic Profile and Effectiveness;Journal of Personalized Medicine;2020-11-25

2. The Combination of DAT-SPECT, Structural and Diffusion MRI Predicts Clinical Progression in Parkinson’s Disease;Frontiers in Aging Neuroscience;2019-03-15

3. Application of 32 Factorial D-Optimal Design in Formulation of Porous Osmotic Pump Tablets of Ropinirole; An Anti-Parkinson’s Agent;Journal of Young Pharmacists;2017-01-10

4. A review of adverse events linked to dopamine agonists in the treatment of Parkinson’s disease;Expert Opinion on Drug Safety;2016-01-20

5. Development and uniform evaluation of ropinirole osmotic pump tablets with REQUIP XL both in vitro and in beagle dogs;Drug Development and Industrial Pharmacy;2015-04-01